Cargando…

Permeability changes and effect of chemotherapy in brain adjacent to tumor in an experimental model of metastatic brain tumor from breast cancer

BACKGROUND: Brain tumor vasculature can be significantly compromised and leakier than that of normal brain blood vessels. Little is known if there are vascular permeability alterations in the brain adjacent to tumor (BAT). Changes in BAT permeability may also lead to increased drug permeation in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammad, Afroz S., Adkins, Chris E., Shah, Neal, Aljammal, Rawaa, Griffith, Jessica I. G., Tallman, Rachel M., Jarrell, Katherine L., Lockman, Paul R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286543/
https://www.ncbi.nlm.nih.gov/pubmed/30526520
http://dx.doi.org/10.1186/s12885-018-5115-x
_version_ 1783379477043085312
author Mohammad, Afroz S.
Adkins, Chris E.
Shah, Neal
Aljammal, Rawaa
Griffith, Jessica I. G.
Tallman, Rachel M.
Jarrell, Katherine L.
Lockman, Paul R.
author_facet Mohammad, Afroz S.
Adkins, Chris E.
Shah, Neal
Aljammal, Rawaa
Griffith, Jessica I. G.
Tallman, Rachel M.
Jarrell, Katherine L.
Lockman, Paul R.
author_sort Mohammad, Afroz S.
collection PubMed
description BACKGROUND: Brain tumor vasculature can be significantly compromised and leakier than that of normal brain blood vessels. Little is known if there are vascular permeability alterations in the brain adjacent to tumor (BAT). Changes in BAT permeability may also lead to increased drug permeation in the BAT, which may exert toxicity on cells of the central nervous system. Herein, we studied permeation changes in BAT using quantitative fluorescent microscopy and autoradiography, while the effect of chemotherapy within the BAT region was determined by staining for activated astrocytes. METHODS: Human metastatic breast cancer cells (MDA-MB-231Br) were injected into left ventricle of female NuNu mice. Metastases were allowed to grow for 28 days, after which animals were injected fluorescent tracers Texas Red (625 Da) or Texas Red dextran (3 kDa) or a chemotherapeutic agent (14)C-paclitaxel. The accumulation of tracers and (14)C-paclitaxel in BAT were determined by using quantitative fluorescent microscopy and autoradiography respectively. The effect of chemotherapy in BAT was determined by staining for activated astrocytes. RESULTS: The mean permeability of texas Red (625 Da) within BAT region increased 1.0 to 2.5-fold when compared to normal brain, whereas, Texas Red dextran (3 kDa) demonstrated mean permeability increase ranging from 1.0 to 1.8-fold compared to normal brain. The K(in) values in the BAT for both Texas Red (625 Da) and Texas Red dextran (3 kDa) were found to be 4.32 ± 0.2 × 10(5) mL/s/g and 1.6 ± 1.4 × 10(5) mL/s/g respectively and found to be significantly higher than the normal brain. We also found that there is significant increase in accumulation of (14)C-Paclitaxel in BAT compared to the normal brain. We also observed animals treated with chemotherapy (paclitaxel (10 mg/kg), erubilin (1.5 mg/kg) and docetaxel (10 mg/kg)) showed activated astrocytes in BAT. CONCLUSIONS: Our data showed increased permeation of fluorescent tracers and (14)C-paclitaxel in the BAT. This increased permeation lead to elevated levels of activated astrocytes in BAT region in the animals treated with chemotherapy.
format Online
Article
Text
id pubmed-6286543
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62865432018-12-14 Permeability changes and effect of chemotherapy in brain adjacent to tumor in an experimental model of metastatic brain tumor from breast cancer Mohammad, Afroz S. Adkins, Chris E. Shah, Neal Aljammal, Rawaa Griffith, Jessica I. G. Tallman, Rachel M. Jarrell, Katherine L. Lockman, Paul R. BMC Cancer Research Article BACKGROUND: Brain tumor vasculature can be significantly compromised and leakier than that of normal brain blood vessels. Little is known if there are vascular permeability alterations in the brain adjacent to tumor (BAT). Changes in BAT permeability may also lead to increased drug permeation in the BAT, which may exert toxicity on cells of the central nervous system. Herein, we studied permeation changes in BAT using quantitative fluorescent microscopy and autoradiography, while the effect of chemotherapy within the BAT region was determined by staining for activated astrocytes. METHODS: Human metastatic breast cancer cells (MDA-MB-231Br) were injected into left ventricle of female NuNu mice. Metastases were allowed to grow for 28 days, after which animals were injected fluorescent tracers Texas Red (625 Da) or Texas Red dextran (3 kDa) or a chemotherapeutic agent (14)C-paclitaxel. The accumulation of tracers and (14)C-paclitaxel in BAT were determined by using quantitative fluorescent microscopy and autoradiography respectively. The effect of chemotherapy in BAT was determined by staining for activated astrocytes. RESULTS: The mean permeability of texas Red (625 Da) within BAT region increased 1.0 to 2.5-fold when compared to normal brain, whereas, Texas Red dextran (3 kDa) demonstrated mean permeability increase ranging from 1.0 to 1.8-fold compared to normal brain. The K(in) values in the BAT for both Texas Red (625 Da) and Texas Red dextran (3 kDa) were found to be 4.32 ± 0.2 × 10(5) mL/s/g and 1.6 ± 1.4 × 10(5) mL/s/g respectively and found to be significantly higher than the normal brain. We also found that there is significant increase in accumulation of (14)C-Paclitaxel in BAT compared to the normal brain. We also observed animals treated with chemotherapy (paclitaxel (10 mg/kg), erubilin (1.5 mg/kg) and docetaxel (10 mg/kg)) showed activated astrocytes in BAT. CONCLUSIONS: Our data showed increased permeation of fluorescent tracers and (14)C-paclitaxel in the BAT. This increased permeation lead to elevated levels of activated astrocytes in BAT region in the animals treated with chemotherapy. BioMed Central 2018-12-07 /pmc/articles/PMC6286543/ /pubmed/30526520 http://dx.doi.org/10.1186/s12885-018-5115-x Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Mohammad, Afroz S.
Adkins, Chris E.
Shah, Neal
Aljammal, Rawaa
Griffith, Jessica I. G.
Tallman, Rachel M.
Jarrell, Katherine L.
Lockman, Paul R.
Permeability changes and effect of chemotherapy in brain adjacent to tumor in an experimental model of metastatic brain tumor from breast cancer
title Permeability changes and effect of chemotherapy in brain adjacent to tumor in an experimental model of metastatic brain tumor from breast cancer
title_full Permeability changes and effect of chemotherapy in brain adjacent to tumor in an experimental model of metastatic brain tumor from breast cancer
title_fullStr Permeability changes and effect of chemotherapy in brain adjacent to tumor in an experimental model of metastatic brain tumor from breast cancer
title_full_unstemmed Permeability changes and effect of chemotherapy in brain adjacent to tumor in an experimental model of metastatic brain tumor from breast cancer
title_short Permeability changes and effect of chemotherapy in brain adjacent to tumor in an experimental model of metastatic brain tumor from breast cancer
title_sort permeability changes and effect of chemotherapy in brain adjacent to tumor in an experimental model of metastatic brain tumor from breast cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286543/
https://www.ncbi.nlm.nih.gov/pubmed/30526520
http://dx.doi.org/10.1186/s12885-018-5115-x
work_keys_str_mv AT mohammadafrozs permeabilitychangesandeffectofchemotherapyinbrainadjacenttotumorinanexperimentalmodelofmetastaticbraintumorfrombreastcancer
AT adkinschrise permeabilitychangesandeffectofchemotherapyinbrainadjacenttotumorinanexperimentalmodelofmetastaticbraintumorfrombreastcancer
AT shahneal permeabilitychangesandeffectofchemotherapyinbrainadjacenttotumorinanexperimentalmodelofmetastaticbraintumorfrombreastcancer
AT aljammalrawaa permeabilitychangesandeffectofchemotherapyinbrainadjacenttotumorinanexperimentalmodelofmetastaticbraintumorfrombreastcancer
AT griffithjessicaig permeabilitychangesandeffectofchemotherapyinbrainadjacenttotumorinanexperimentalmodelofmetastaticbraintumorfrombreastcancer
AT tallmanrachelm permeabilitychangesandeffectofchemotherapyinbrainadjacenttotumorinanexperimentalmodelofmetastaticbraintumorfrombreastcancer
AT jarrellkatherinel permeabilitychangesandeffectofchemotherapyinbrainadjacenttotumorinanexperimentalmodelofmetastaticbraintumorfrombreastcancer
AT lockmanpaulr permeabilitychangesandeffectofchemotherapyinbrainadjacenttotumorinanexperimentalmodelofmetastaticbraintumorfrombreastcancer